You are here
Professor Ravi Savarirayan
Professor Ravi Savarirayan is a clinical geneticist and Group Leader of Skeletal Biology and Disease at Murdoch Childrens Research Institute. He is also Head of Clinical Genetics Services at the Victorian Clinical Genetic Services.
Ravi's primary clinical and research focus are the inherited disorders of the skeleton causing short stature, arthritis and osteoporosis.
He is the Foundation Director of the Southern Cross Bone Dysplasia Centre and immediate past-President of the International Skeletal Dysplasia Society (ISDS) and was the first Australian to hold this post.
He has won numerous academic awards including the Fulbright Professional Scholarship for Australia that took him to Los Angeles in 1999 for further studies in the field of bone disorders.
He pursued his doctoral studies in the clinical and molecular aspects of these disorders and has published over 150 peer-reviewed scientific journal papers. He conducts diagnosis and management clinics for patients and their families with these conditions throughout Australasia, and is an invited expert case-manager for the European Skeletal Dysplasia Network.
Professor Savarirayan's international reputation in the field has been demonstrated by being invited to deliver the opening scientific address at the Combined International Congress of Orthopaedic Associations, held every seven years.
- Head of Clinical Genetics Services at the Victorian Clinical Genetic Services
- Invited Expert Panel member (World Health Organization) – Geneva, February 23rd-25th 2014 on Thalidomide
- President, International Skeletal Dysplasia Society 2009-2011. Peak body for classification, diagnosis, and management of skeletal dysplasias worldwide (elected office)
- European Skeletal Dysplasia Network, Elected Expert Case Manager 2005-onwards
- Invited by Singapore Government as Expert visitor in Medicine for 2009 (Field: Clinical Genetics, visit Feb 23rd-27th 2009)
- Invited Plenary speaker at scientific conferences in Europe (Belgium, France, England, Denmark); Asia (Korea, Singapore, India); North America (USA, Canada); Middle East (Saudi Arabia) and Australia
- Invited International Grants assessor, Australia, Hong Kong, Italy, France, England
- Editorial Board: 4 international, high impact journals spanning Europe, North America, Britain and Australia (Human Mutation, European Journal Human Genetics, American Journal Medical Genetics, Journal Medical Genetics): Only Australian in 2 cases (EJHG, AJMG)
- Elected to International Scientific excellence board, Christian Medical College, India (No 1 ranked medical school in India), 2003-onwards
- Invited member of International Working Committee on Constitutional Diseases of Bone. Nomenclature Group, St John's College, Oxford, September 2001, Martigny, Switzerland August 2005, Boston USA July 2009, Bologna Italy 2013
- Professeur Invité, René Descartes University, Paris 2006 (paid position)
- Fulbright Professional Scholar for Australia 1998-1999
Translational outcomes of basic/clinical research, such as clinical drug trials, natural history studies and best practice guidelines for management based on current evidence.
Skeletal dysplasia and connective tissue disorders: diagnosis, management, new gene discovery, and treatment based on pathogenesis.
Delivery of genetic services to Indigenous Australians and Ensuring equal access of All Australian to New Genomics Innovation.
- Clinical trial of CNP for achondroplasia
- Ozcleft NHMRC project
- Skeletal dysplasias natural history studies